Artificial Intelligence

Making its CES debut, Cearvol unveils smart glasses and open-ear aids powered by advanced AI, challenging the stigma of traditional hearing devices.

Principal Financial is set to unveil its 2026 forecast. Investors weigh strong 2025 results against analyst caution and shifting economic tides.

China's JIADE LIMITED partners with South Korea's Chinalink, leveraging AI to expand education services to North America, Asia, and the Middle East.

SPAR Group appoints a CPG veteran to lead North American sales while top executives make significant share purchases, signaling strong internal confidence.

Known for hair styling, Wavytalk is launching a clinically-tested LED mask. Can this at-home device truly rival professional skincare treatments?

Lantheus sells its legacy SPECT business to fusion-tech firm SHINE, sharpening its focus on high-growth PET diagnostics and next-gen cancer therapies.

Fintech pioneer Currenc Group divests its payments hub Tranglo in a $400M deal, fueling a bold transformation into AI, Web3, and digital assets.

With a blockbuster 2025 in the books, Boston Scientific's leadership faces intense scrutiny at upcoming investor events to prove its growth is sustainable.

Genelux appoints Dr. Jason Litten as CMO, a strategic move to steer its promising oncolytic virus, Olvi-Vec, through crucial late-stage cancer trials.

Debuting at CES, MetaGuard AI's new platform offers an industry-first: full source code access, blending defense-grade AI with neuromorphic tech.

Clicks Technology launches a smartphone with a physical keyboard, betting that users want a focused companion for communication, not another distraction.

As robotaxis and self-driving trucks go commercial, a new group from Seeing Machines aims to solve the critical human trust and safety challenge.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

With patent cliffs looming and big bets on M&A, all eyes are on BMS to prove its growth strategy and high-stakes pipeline can deliver in 2026.

At CES 2026, PETKIT unveiled an AI ecosystem that turns feeders and litter boxes into health monitors, promising to catch illnesses in pets early.

Smart cart maker A2Z Cust2Mate pivots for hyper-growth as its visionary founder exits, leaving the CEO as interim chair to steer a global expansion strategy.

Bitcoin miner Bitfarms sells its last Latin American asset for $30M, pivoting fully to the booming North American AI and HPC infrastructure market.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

With strong growth and key acquisitions, Haemonetics' CEO will lay out the company's vision for 2026 at a high-stakes investor conference.

Amidst a market downturn, CNH brings in leaders from Rivian and Nikola to spearhead its ambitious transformation in autonomy, AI, and global operations.